Background: Present study aimed to evaluate the association between blood eosinophil count and tissue eosinophil grading among patients suffering from Sinonasal Polyposisattending routine ENT OPD in Dr. RPGMC Tanda. Material and Methods: The present study was done as a hospital based cross sectional study in the department of ENT & Head and Neck Surgery, in Dr. RPGMC Kangra at Tanda. It was done in 30 patients of chronic rhinosinusitis with nasal polyposis (CRSwNP) from June 2018 to June 2019 who met the inclusion criteria. Data regardingBlood & Tissue eosinophil count was retrieved. Results: in the present study, there were a total of 30 patients out of which there were 16 males and 14 females. The mean age observed of patients was 42.47±13.68. Among the total, 17 patients were classified as Eosinophilic Chronic Rhinosinusitis with Nasal Polyposis (ECRSwNP) while 13 were classified as Non-Eosinophilic Chronic Rhinosinusitis with Nasal Polyposis (NECRSwNP). There were 9 cases of ECRSwNP where tissue eosinophils were >10/HPF while 8 cases had <10 tissue eosinophils/HPF. Similarly, 9 cases of NECRSwNP had <10 tissue eosinophils/HPF while 4 cases had tissue eosinophils were >10/HPF. The association between blood eosinophil count and tissue eosinophil grading was not significant with p value of 0.225. Conclusion: Present study concluded that there was no significant association of blood eosinophil count between NECRSwNP and ECRSwNP with tissue eosinophils.
Majority of nasal polyps result as a consequence of chronic mucosal inflammation. Recurrent attacks of rhinitis eventually lead to focal protrusion of the mucosa leading to the formation of nasal polyp [1]. Once present and when activated, eosinophils lead to the damage of mucosa through degranulation and release of toxic mediators with resulting epithelial sloughing and tissue edema [2-4].
In contrasts to United States or Europe, studies showed that in Eastern Asian population about >50% of cases of CRS with Nasal polyposis are non-eosinophilic dominant and that in some samples, neutrophils are the dominant cell type characterized by mixed T helper cell type 1 (Th1) or Th17 type inflammation [5-7]. So it has been suggested to classify CRSwNP into “eosinophilic” and “noneosinophilic” according to eosinophil infiltration within Nasal Polyp.
Previous data showed that blood eosinophilia and the extent of eosinophilic inflammation is related to the extent of sinonasal mucosal involvement, the severity of nasal disease and size of nasal polyps suggesting that Chronic rhinosinusitis (CRS) with and without Nasal polyposis (NP) represent two ends of a spectrum of chronic inflammatory disease [8,9].
There is paucity of research with respect to Blood eosinophil count and tissue eosinophil grading among patients suffering from Sinonasal Polyposis in Himachal Pradesh. Therefore, the present study is undertaken to determine the association between blood eosinophil counts and eosinophil count in histopathological specimen in CRSwNP patients attending routine ENT OPD in Dr. RPGMC Tanda.
Aim and Objective
To evaluate the association between blood eosinophil counts and eosinophil count in histopathological specimen in CRSwNP patients attending routine ENT OPD in Dr. RPGMC Tanda.
Source of Data
Patients suffering from Sinonasal Polyposis attending routine ENT OPD in Dr. RPGMC Tanda.
Methods of Collection of Data
Study Area: Department of ENT, Head and Neck Surgery in Dr. RPGMC Tanda.
Study Population
30 patients of Chronic Rhinosinusitis with Nasal Polyposis.
Study Design
Hospital based cross sectional study.
Study Period
One Year, i.e. from June 2018 to June 2019.
Inclusion Criteria
Study population included adult population (>18 years) suffering from CRSwNP who were not taking any treatment at least for the last 1-2 weeks, diagnosis being made on basis of history and clinical examination.
Clinically patient having following symptom was included:
Sneezing
Itching in nose, eyes, ears and palate
Nasal discharge
Nasal obstruction
Loss of smell
Facial Pain or pressure
Headache
Nasal polyposis
Patients not on medication for the past 2 week.
All patients willing to give consent.
Exclusion Criteria
Patients didn’t willing to give consent.
Patients aged <18 years.
Patients suffering from diseases like:
DNS
Adenoid hypertrophy
History of Sinonasal surgeries (for recurrent nasal polyp)
Patients with cystic fibrosis
Patients suffering from fungal sinusitis
Patients with immunotherapy
Pregnancy
Nasal neoplasm
Patients who have used nasal, inhaled or systemic steroids within 2 months
Chronic bronchitis
Bronchial asthma
Methodology and Type of Data Collected
Present study was conducted in the Department of ENT in Dr RPGMC Tanda, after obtaining clearance and approval from the institutional ethical committee; patients fulfilling the inclusion/exclusion criteria were included in the study after obtaining informed consent. Blood drawn from median cubital vein under all aseptic conditions in labelled EDTA vial for each patient was sent to centralized laboratory of the Institute for complete haemogram test and thus peripheral blood eosinophil count was obtained in all patients prior to surgery.
Blood eosinophil count ≥ 6 % of differential leucocyte count in CRSwNP patient is taken as Eosinophilic CRSwNP while values ≥ 6% are considered as Non eosinophilic CRSwNP.
Following endoscopic sinus surgery, the biopsy of the polyp was sent for histopathological study in the Department of Pathology Dr. RPGMC Tanda. Samples were fixed with formaldehyde solution and later with haematoxylin and eosin staining. Slides were examined for tissue eosinophil count. Tissue eosinophil count was graded as 0, 1+ and 2+ where 0 is no eosinophils while 1+ is occasional or less than 10 eosinophils and 2+ being more than 10 eosinophils /HPF in the sample slide.
Eosinophilic CRSwNP was defined when tissue eosinophil count was >10/HPF or tissue eosinophil count grade 2+. Both the counts (eosinophilic blood count and histopathological eosinophil count) were compared to know the relation and significance of eosinophil count in sinonasal polyposis.
Statistical Analysis
The data entry and analysis was done in Microsoft Office Excel 2007 and Epi Info software. Descriptive analysis was done using frequency, percentages and Mean (+/-S.D.). Association between Absolute Eosinophil count and histopathological eosinophil count between non eosinophilic chronic rhino sinusitis (NECRSwNP) and in eosinophilic chronic rhinosinusitis (ECRSwNP) groups was determined by applying student ‘t’ test. p value <0.05 was taken as statistically significant.
The present study was carried out in the Department of ENT, Head and Neck Surgery at Dr. RPGMC Tanda (Himachal Pradesh) from June 2018 to June 2019. A total of 30 patients were enrolled into the study. The results of which are as below: There were a total of 30 patients of Chronic Rhinosinusitis with Nasal Polyposis, out of which there were 16 males and 14 females with male to female ratio of 1.14:1. The mean age of all patients was 42.47±13.68 ranging from 21 to 79 years. The mean age of males was 45.88±13.3 and mean age of females was 38.57±13.53 which was less than that of males (Table 1). Among the total 30 patients, 17 were classified as Eosinophilic Chronic Rhinosinusitis with Nasal Polyposis (ECRSwNP) while 13 were classified as Non-Eosinophilic Chronic Rhinosinusitis with Nasal Polyposis (NECRSwNP) (Figure 1).
There were 9 cases of ECRSwNP where tissue eosinophils were >10/HPF while 8 cases had <10 tissue eosinophils/HPF. Similarly, 9 cases of NECRSwNP had <10 tissue eosinophils/HPF while 4 cases had tissue eosinophils were >10/HPF. The association between blood eosinophil count and tissue eosinophil grading was not significant with p value of 0.225 (Table 2).
The scattered plot diagram also showed that there is positive relation between tissue eosinophil and peripheral eosinophil count but the relation is not significant (Figure 2).
Table 1: Age and Gender Wise Distribution of Patients
Gender | Frequency (Number) | Percentage | Mean Age ±SD | Range |
Males | 16 | 53.3 | 45.88±13.3 | 22-79 |
Females | 14 | 46.7 | 38.57±13.53 | 21-65 |
Total | 30 | 100 | 42.47±13.68 | 21-79 |
Table 2: Comparison of Peripheral Eosinophil Count with Tissue Eosinophil Count in CRS Patients with and without Eosinophilia
Blood Eosinophil Count | Tissue Eosinophil Grading | p value | |
1+ (<10/Hpf) | 2+ (>10/Hpf) | ||
CRS Without Eosinophilia | 9 | 4 | 0.225 |
CRS With Eosinophilia | 8 | 9 | |

Figure 1: Classification of Patients into ECRSwNP and NECRSwNP

Figure 2: Scattered Plot Diagram Showed Positive Relation between Tissue Eosinophil Count and Peripheral Eosinophil Count
The present study was carried out in the Department of ENT, Head and Neck Surgery at Dr. RPGMC Tanda (Himachal Pradesh) including 30 patients of Chronic Rhinosinusitis with Nasal Polyposis which were further classified into “Eosinophilic” and “Non eosinophilic” CRS with Nasal polyposis bases on operational definition.
In study by Cao PP et al. [10] the association of blood eosinophil count between NECRSwNP and ECRSwNP with tissue eosinophil was significant (P value <0.001) similar to another study by Aslan F. et al. [11] which observed significant association between tissue and peripheral eosinophilia (p value <0.001) while in our study, there was no significant association of blood eosinophil count between NECRSwNP and ECRSwNP with tissue eosinophil count and p value found was 0.225. This may be attributed due to smaller number of patients in study group and shorter study period than other similar studies. Also, this might be due to geographical variations and easy availability of medication without prescription in our health set up in India as our study group patients were more symptomatic compared to other study groups.
Conclusion and Recommendation
In our study we did not find any significant correlation between the peripheral eosinophil count and tissue eosinophil count as on histological examination and the difference between eosinophilic and noneosinophilic group was also not found significant statistically. This could be due to smaller sample size, geographical variation and noncompliance with antihistaminics and INCS due to easy availability of non-prescriptive medication. So, a further larger sample size study is required to study the relation between peripheral eosinophil count and tissue eosinophil count.
Kumar, V. et al. Pathologic Basis of Disease. 7th ed., Saunders, 2004.
Harlin, S.L. et al. “A clinical and pathological study of chronic sinusitis: Role of the eosinophil.” Journal of Allergy and Clinical Immunology, vol. 81, 1988, pp. 867–875.
Bernardes, J.F. et al. “Protein nitration in chronic sinusitis and nasal polyposis: Role of eosinophils.” Otolaryngology–Head and Neck Surgery, vol. 131, no. 5, 2004, pp. 696–703.
Bachert, C. et al. “Nasal polyposis: From cytokines to growth.” American Journal of Rhinology, vol. 14, no. 5, 2000, pp. 279–290.
Cao, P.P. et al. “Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese.” Journal of Allergy and Clinical Immunology, vol. 124, nos. 1–2, 2009, pp. 478–484.
Kim, J.W. et al. “Histological and immunological features of non-eosinophilic nasal polyps.” Otolaryngology–Head and Neck Surgery, vol. 137, 2007, pp. 925–930.
Ikeda, K. et al. “Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil.” Laryngoscope, vol. 123, 2013, pp. 1–9.
Bryson, J.M. et al. “Local and systemic eosinophilia in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis with and without polyposis.” Clinical Otolaryngology, vol. 28, 2003, pp. 55–58.
Staikuniene, J. et al. “Association of chronic rhinosinusitis with nasal polyps and asthma: Clinical and radiological features, allergy and inflammation markers.” Medicina, vol. 44, no. 4, 2008, pp. 257–265.
Cao, P.P. et al. “Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese.” Journal of Allergy and Clinical Immunology, vol. 124, nos. 1–2, 2009, pp. 478–484.
Aslan, F. et al. “Could eosinophilia predict clinical severity in nasal polyps.” Multidisciplinary Respiratory Medicine, vol. 12, August 2017, article 21.